• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青春期和成年多囊卵巢综合征女性的代谢和肥胖生物标志物比较。

Comparison of metabolic and obesity biomarkers between adolescent and adult women with polycystic ovary syndrome.

机构信息

Department of Gynecology and Obstetrics, Medical School, Federal University of Mato Grosso, Cuiabá, MT, 78 043 306, Brazil.

Tropical Institute of Reproductive Medicine, Cuiabá, MT, Brazil.

出版信息

Arch Gynecol Obstet. 2021 Mar;303(3):739-749. doi: 10.1007/s00404-020-05867-x. Epub 2020 Nov 17.

DOI:10.1007/s00404-020-05867-x
PMID:33201375
Abstract

PURPOSE

Knowledge of adolescent and adult phenotypes of women with polycystic ovary syndrome (PCOS) might drive opportune management. The aim of this study was to compare metabolic and obesity biomarkers between adolescent and adult women with PCOS.

METHODS

This observational study compared biomarkers of obesity and metabolism derangements between adolescent (n = 62) and adult (n = 248) women with PCOS. Predictors of metabolic syndrome (MS) were investigated using univariate and multivariate binary logistic regression analysis.

RESULTS

The postmenarcheal age of adolescents was 4.9 ± 0.03 years. Systolic blood pressure was lower in adolescents than in adults (112.3 mmHg vs 117.0 mmHg, p = 0.001) Diastolic blood pressure was also lower in adolescents (70.7 mmHg vs 75.8 mmHg, p < 0.001). Glucose intolerance (12.0% vs 19.3%) and insulin resistance (18.2% vs 17.7%) were similar in both groups (p > 0.05, for comparisons). Impaired fasting glucose was lower in adolescents (1.8% vs 11.6%, p = 0.015). Total cholesterol and low-density lipoprotein cholesterol were lower in adolescents (p < 0.001). MS in adolescents and adults were found in 10.3% and 27.8%, respectively (p = 0.005). Visceral adiposity index (VAI) was a good predictor of MS in both adolescents (OR = 12.2), and adults (OR = 9.7).

CONCLUSIONS

Most biomarkers of glucose metabolism abnormalities were similar in adolescents and adults with PCOS. The prevalence of MS was lower in adolescents. VAI was a strong predictor of metabolic syndrome, both in adolescent and adult women with PCOS.

摘要

目的

了解多囊卵巢综合征(PCOS)女性的青少年和成年表型可能有助于及时治疗。本研究旨在比较青少年和成年 PCOS 女性的代谢和肥胖生物标志物。

方法

本观察性研究比较了 62 名青少年和 248 名成年 PCOS 女性的肥胖和代谢紊乱生物标志物。使用单变量和多变量二元逻辑回归分析研究了代谢综合征(MS)的预测因素。

结果

青少年的初潮年龄为 4.9±0.03 岁。青少年的收缩压低于成年人(112.3mmHg 比 117.0mmHg,p=0.001),舒张压也较低(70.7mmHg 比 75.8mmHg,p<0.001)。两组葡萄糖耐量异常(12.0%比 19.3%)和胰岛素抵抗(18.2%比 17.7%)相似(p>0.05)。青少年空腹血糖受损发生率较低(1.8%比 11.6%,p=0.015)。青少年的总胆固醇和低密度脂蛋白胆固醇水平较低(p<0.001)。青少年和成年患者的 MS 发生率分别为 10.3%和 27.8%(p=0.005)。在青少年(OR=12.2)和成年(OR=9.7)患者中,内脏脂肪指数(VAI)是 MS 的良好预测因子。

结论

青少年和成年 PCOS 患者的葡萄糖代谢异常生物标志物大多相似。青少年的 MS 患病率较低。VAI 是青少年和成年 PCOS 患者代谢综合征的强有力预测因子。

相似文献

1
Comparison of metabolic and obesity biomarkers between adolescent and adult women with polycystic ovary syndrome.青春期和成年多囊卵巢综合征女性的代谢和肥胖生物标志物比较。
Arch Gynecol Obstet. 2021 Mar;303(3):739-749. doi: 10.1007/s00404-020-05867-x. Epub 2020 Nov 17.
2
The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome.内脏脂肪指数在肥胖和非肥胖多囊卵巢综合征妇女代谢综合征预测中的作用。
Metab Syndr Relat Disord. 2021 Feb;19(1):18-25. doi: 10.1089/met.2020.0045. Epub 2020 Aug 25.
3
Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis.肥胖对青少年多囊卵巢综合征的代谢影响:一项荟萃分析。
J Obstet Gynaecol. 2017 Nov;37(8):1036-1047. doi: 10.1080/01443615.2017.1318840. Epub 2017 Jun 28.
4
Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.中国大规模多囊卵巢综合征女性临床特征分析
Neuro Endocrinol Lett. 2007 Dec;28(6):807-10.
5
A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome.多囊卵巢综合征女性中一种与内脏脂肪指数相关的饮食模式及心脏代谢特征
Clin Nutr. 2016 Oct;35(5):1181-7. doi: 10.1016/j.clnu.2015.10.007. Epub 2015 Nov 25.
6
[Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].[多囊卵巢综合征青春期女孩的肥胖、激素及代谢异常]
Orv Hetil. 2013 Aug 4;154(31):1226-34. doi: 10.1556/OH.2013.29669.
7
Utility of the Oral Glucose Tolerance Test to Assess Glucose Abnormalities in Adolescents with Polycystic Ovary Syndrome.口服葡萄糖耐量试验在评估多囊卵巢综合征青少年葡萄糖异常方面的效用
J Pediatr Adolesc Gynecol. 2016 Feb;29(1):48-52. doi: 10.1016/j.jpag.2015.06.004. Epub 2015 Jun 11.
8
Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.多囊卵巢综合征中肥胖和胰岛素抵抗的代谢后果:诊断和方法学挑战。
Nutr Res Rev. 2017 Jun;30(1):97-105. doi: 10.1017/S0954422416000287. Epub 2017 Feb 22.
9
Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.多囊卵巢综合征育龄妇女2型糖尿病和心血管疾病风险概况的综合评估:一项大型加拿大队列研究
J Obstet Gynaecol Can. 2019 Oct;41(10):1453-1460. doi: 10.1016/j.jogc.2018.11.026. Epub 2019 Feb 1.
10
Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.多囊卵巢综合征(PCOS)的早期内分泌、代谢及超声特征:非肥胖与肥胖青少年的比较
J Clin Endocrinol Metab. 2003 Oct;88(10):4682-8. doi: 10.1210/jc.2003-030617.

引用本文的文献

1
Combined oral contraceptive use and obesity in women with polycystic ovary syndrome. A meta-analysis of randomized clinical trials.多囊卵巢综合征妇女中口服避孕药与肥胖的联合应用。随机临床试验的荟萃分析。
Arch Gynecol Obstet. 2024 Oct;310(4):2223-2233. doi: 10.1007/s00404-024-07637-5. Epub 2024 Jul 18.
2
Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome.多囊卵巢综合征女性的月经功能障碍严重程度与心血管代谢风险标志物的相关性。
Acta Obstet Gynecol Scand. 2024 Aug;103(8):1606-1614. doi: 10.1111/aogs.14863. Epub 2024 May 7.
3
Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome.

本文引用的文献

1
Adolescent polycystic ovary syndrome according to the international evidence-based guideline.青少年多囊卵巢综合征的国际循证指南。
BMC Med. 2020 Mar 24;18(1):72. doi: 10.1186/s12916-020-01516-x.
2
Changes in clinical and biochemical characteristics of polycystic ovary syndrome with advancing age.多囊卵巢综合征的临床和生化特征随年龄增长的变化。
Endocr Connect. 2020 Feb;9(2):74-89. doi: 10.1530/EC-19-0496.
3
Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndrome.青少年与青年多囊卵巢综合征患者表型差异极小。
多囊卵巢综合征年轻女性2型糖尿病风险评估
Diagnostics (Basel). 2023 Jun 14;13(12):2067. doi: 10.3390/diagnostics13122067.
4
Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review : PCOS and COVID-19 relationship.多囊卵巢综合征与 COVID-19 感染风险:全面综述:PCOS 与 COVID-19 的关系。
Rev Endocr Metab Disord. 2022 Apr;23(2):251-264. doi: 10.1007/s11154-022-09715-y. Epub 2022 Feb 26.
5
Cardiovascular Risk Factors and Subclinical Atherosclerosis in Greek Adolescents with Polycystic Ovary Syndrome: Its Relationship with Body Mass Index.希腊多囊卵巢综合征青少年的心血管危险因素与亚临床动脉粥样硬化:其与体重指数的关系
Children (Basel). 2021 Dec 22;9(1):4. doi: 10.3390/children9010004.
6
Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility.胰岛素抵抗肥胖青少年多囊卵巢综合征:营养治疗和食品补充剂作为保护生育力策略的作用。
Nutrients. 2021 May 28;13(6):1848. doi: 10.3390/nu13061848.
Fertil Steril. 2019 Feb;111(2):389-396. doi: 10.1016/j.fertnstert.2018.10.020. Epub 2018 Dec 7.
4
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.国际循证指南关于多囊卵巢综合征评估和管理的推荐意见。
Fertil Steril. 2018 Aug;110(3):364-379. doi: 10.1016/j.fertnstert.2018.05.004. Epub 2018 Jul 19.
5
New Diagnostic Criteria of Polycystic Ovarian Morphology for Adolescents: Impact on Prevalence and Hormonal Profile.青少年多囊卵巢形态的新诊断标准:对患病率和激素谱的影响。
Horm Res Paediatr. 2017;88(6):401-407. doi: 10.1159/000481532. Epub 2017 Oct 19.
6
Polycystic ovary syndrome throughout a woman's life.女性一生中的多囊卵巢综合征
J Assist Reprod Genet. 2018 Jan;35(1):25-39. doi: 10.1007/s10815-017-1047-7. Epub 2017 Sep 27.
7
Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype.根据多囊卵巢综合征表型的代谢综合征和代谢风险概况
J Obstet Gynaecol Res. 2016 Jul;42(7):837-43. doi: 10.1111/jog.12985. Epub 2016 Apr 13.
8
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.美国临床内分泌医师协会、美国内分泌学会以及雄激素过多与多囊卵巢综合征协会疾病状态临床综述:多囊卵巢综合征评估与治疗最佳实践指南 - 第2部分。
Endocr Pract. 2015 Dec;21(12):1415-26. doi: 10.4158/EP15748.DSCPT2.
9
The Diagnosis of Polycystic Ovary Syndrome in Adolescents.青少年多囊卵巢综合征的诊断
Pediatrics. 2015 Dec;136(6):1154-65. doi: 10.1542/peds.2015-1430.
10
Metabolic effects of polycystic ovary syndrome in adolescents.青少年多囊卵巢综合征的代谢影响
Ann Pediatr Endocrinol Metab. 2015 Sep;20(3):136-42. doi: 10.6065/apem.2015.20.3.136. Epub 2015 Sep 30.